Allakos Inc (ALLK)
1.01
-0.01
(-0.98%)
USD |
NASDAQ |
Apr 25, 16:00
1.00
-0.01
(-0.99%)
Pre-Market: 20:00
Allakos Cash from Financing (TTM): 2.528M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 2.528M |
September 30, 2023 | 2.718M |
June 30, 2023 | 142.93M |
March 31, 2023 | 142.99M |
December 31, 2022 | 141.88M |
September 30, 2022 | 142.56M |
June 30, 2022 | 5.09M |
March 31, 2022 | 5.824M |
December 31, 2021 | 10.26M |
September 30, 2021 | 284.21M |
June 30, 2021 | 281.92M |
March 31, 2021 | 282.83M |
December 31, 2020 | 278.84M |
Date | Value |
---|---|
September 30, 2020 | 4.031M |
June 30, 2020 | 382.56M |
March 31, 2020 | 380.99M |
December 31, 2019 | 381.16M |
September 30, 2019 | 381.16M |
June 30, 2019 | 141.12M |
March 31, 2019 | 140.16M |
December 31, 2018 | 138.75M |
September 30, 2018 | 225.85M |
June 30, 2018 | 93.28M |
March 31, 2018 | 94.17M |
December 31, 2017 | 94.62M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
2.528M
Minimum
Dec 2023
382.56M
Maximum
Jun 2020
178.72M
Average
142.93M
Median
Jun 2023
Cash from Financing (TTM) Benchmarks
Tonix Pharmaceuticals Holding Corp | 36.52M |
RAPT Therapeutics Inc | 1.447M |
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |